FDA also suggests the application address acute toxicity, which fears the ability of the chemical agent to trigger adverse results just after both an individual publicity or a number of exposures in a brief length of time (normally a lot less than 24 hours).an facet of the manufacturing method that results in reduced amounts of HPHCs than other tob